Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8386426rdf:typepubmed:Citationlld:pubmed
pubmed-article:8386426lifeskim:mentionsumls-concept:C0007776lld:lifeskim
pubmed-article:8386426lifeskim:mentionsumls-concept:C0030580lld:lifeskim
pubmed-article:8386426lifeskim:mentionsumls-concept:C0020291lld:lifeskim
pubmed-article:8386426lifeskim:mentionsumls-concept:C0031621lld:lifeskim
pubmed-article:8386426lifeskim:mentionsumls-concept:C0034826lld:lifeskim
pubmed-article:8386426lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8386426lifeskim:mentionsumls-concept:C1704666lld:lifeskim
pubmed-article:8386426lifeskim:mentionsumls-concept:C1517892lld:lifeskim
pubmed-article:8386426lifeskim:mentionsumls-concept:C2347957lld:lifeskim
pubmed-article:8386426lifeskim:mentionsumls-concept:C0208973lld:lifeskim
pubmed-article:8386426pubmed:issue3lld:pubmed
pubmed-article:8386426pubmed:dateCreated1993-5-17lld:pubmed
pubmed-article:8386426pubmed:abstractTextHydrolysis of inositol phospholipids caused by muscarinic agonists was studied in the guinea-pig parotid gland (PG) and cerebral cortex (CX). The present study describes the effect of two muscarinic agonists, carbachol and oxotremorine, on stimulation of phosphoinositide hydrolysis and on binding of [3H]NMS in the presence of the irreversible muscarinic antagonist benzilyl choline mustard (BCM). Carbachol and oxotremorine stimulated the formation of inositol phosphates in PG, pD2(Carb) = 5.3 +/- 0.1, pD2(Oxo) = 5.9 +/- 0.1 and in CX, pD2(Carb) = 4.3 +/- 0.2, pD2(Oxo) = 5.8 +/- 0.2. In the present study slices from both tissues have been exposed to 0.1 microM BCM for 2, 5 and 10 min. Treatment for 10 min caused a 75-85% reduction in specific [3H]N-methyl scopolamine ([3H]NMS) binding sites in both PG and CX. Following 2 min BCM treatment of PG a marked decrease in pD2 value of the carbachol-stimulated inositol phosphate formation was found. This effect was not found in CX. The results showed that a 30-40% reduction in binding sites shifted the carbachol concentration response curve to the right by one order of magnitude and reduced the oxotremorine-induced release of inositol phosphates by approximately 20%. In PG, the BCM-induced reduction of the carbachol-stimulated inositol phosphate formation was paralleled by the reduction in receptor binding sites. Similar treatment, but in CX, showed a lower reduction of the carbachol-stimulated inositol phosphate formation as compared to the reduction in receptor-binding sites.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:8386426pubmed:languageenglld:pubmed
pubmed-article:8386426pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386426pubmed:citationSubsetIMlld:pubmed
pubmed-article:8386426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8386426pubmed:statusMEDLINElld:pubmed
pubmed-article:8386426pubmed:monthMarlld:pubmed
pubmed-article:8386426pubmed:issn0001-6772lld:pubmed
pubmed-article:8386426pubmed:authorpubmed-author:EkBBlld:pubmed
pubmed-article:8386426pubmed:authorpubmed-author:AntonssonB...lld:pubmed
pubmed-article:8386426pubmed:issnTypePrintlld:pubmed
pubmed-article:8386426pubmed:volume147lld:pubmed
pubmed-article:8386426pubmed:ownerNLMlld:pubmed
pubmed-article:8386426pubmed:authorsCompleteYlld:pubmed
pubmed-article:8386426pubmed:pagination289-95lld:pubmed
pubmed-article:8386426pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:meshHeadingpubmed-meshheading:8386426-...lld:pubmed
pubmed-article:8386426pubmed:year1993lld:pubmed
pubmed-article:8386426pubmed:articleTitleStudies of muscarinic receptor reserve linked to phosphoinositide hydrolysis in parotid gland and cerebral cortex.lld:pubmed
pubmed-article:8386426pubmed:affiliationDepartment of Physiology, University of Gothenburg, Sweden.lld:pubmed
pubmed-article:8386426pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8386426pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8386426pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8386426lld:pubmed